Pharmacovigilance and Drug Safety Software - Global Strategic Business Report 2026-2032 Featuring Oracle, ArisGlobal, Ennov, Extedo and More

Tłumaczenie nie jest jeszcze gotowe. Wyświetlamy oryginalny artykuł.

Company Logo Dublin, Nov. 05, 2026 (GLOBE NEWSWIRE) -- "Pharmacovigilance and Drug Safety Software - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global pharmacovigilance and drug safety software market was valued at US$227.4 million in 2025 and is projected to reach US$336.5 million by 2032, expanding at a compound annual growth rate (CAGR) of 5.8%. Market growth is supported by increasingly stringent regulatory requirements, rising adverse event data volumes, greater global pharmaceutical consumption, and demand for real-time drug safety monitoring and advanced analytics.